BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20451677)

  • 1. Volumetric analysis of osteoclastic bioresorption of calcium phosphate ceramics with different solubilities.
    Winkler T; Hoenig E; Gildenhaar R; Berger G; Fritsch D; Janssen R; Morlock MM; Schilling AF
    Acta Biomater; 2010 Oct; 6(10):4127-35. PubMed ID: 20451677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of osteoclast-like cells on HA and TCP ceramics.
    Detsch R; Mayr H; Ziegler G
    Acta Biomater; 2008 Jan; 4(1):139-48. PubMed ID: 17723325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclastogenesis on hydroxyapatite ceramics: the effect of carbonate substitution.
    Spence G; Patel N; Brooks R; Bonfield W; Rushton N
    J Biomed Mater Res A; 2010 Mar; 92(4):1292-300. PubMed ID: 19343778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution rate of zinc-containing beta-tricalcium phosphate ceramics.
    Ito A; Senda K; Sogo Y; Oyane A; Yamazaki A; Legeros RZ
    Biomed Mater; 2006 Sep; 1(3):134-9. PubMed ID: 18458394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclastic resorption of calcium phosphate ceramics with different hydroxyapatite/beta-tricalcium phosphate ratios.
    Yamada S; Heymann D; Bouler JM; Daculsi G
    Biomaterials; 1997 Aug; 18(15):1037-41. PubMed ID: 9239465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-based resorption assays for bone graft substitutes.
    Zhang Z; Egaña JT; Reckhenrich AK; Schenck TL; Lohmeyer JA; Schantz JT; Machens HG; Schilling AF
    Acta Biomater; 2012 Jan; 8(1):13-9. PubMed ID: 21971416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclastic bioresorption of biomaterials: two- and three-dimensional imaging and quantification.
    Winkler T; Hoenig E; Huber G; Janssen R; Fritsch D; Gildenhaar R; Berger G; Morlock MM; Schilling AF
    Int J Artif Organs; 2010 Apr; 33(4):198-203. PubMed ID: 20458689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biodegradation of synthetic bioglasses with different crystallinity in vitro].
    Zhang Y; Cai Y; Wang Q; Zhao Y; Monchau F; Lefevre A; Hildebrand HF
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Oct; 22(5):990-4. PubMed ID: 16294737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro: osteoclastic activity studies on surfaces of 3D printed calcium phosphate scaffolds.
    Detsch R; Schaefer S; Deisinger U; Ziegler G; Seitz H; Leukers B
    J Biomater Appl; 2011 Sep; 26(3):359-80. PubMed ID: 20659962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced bioceramic composite for bone tissue engineering: design principles and structure-bioactivity relationship.
    El-Ghannam AR
    J Biomed Mater Res A; 2004 Jun; 69(3):490-501. PubMed ID: 15127396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro.
    Faucheux C; Verron E; Soueidan A; Josse S; Arshad MD; Janvier P; Pilet P; Bouler JM; Bujoli B; Guicheux J
    J Biomed Mater Res A; 2009 Apr; 89(1):46-56. PubMed ID: 18404716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of RANKL promotes osteoclast formation and osteoclast activity on β-TCP ceramics.
    Choy J; Albers CE; Siebenrock KA; Dolder S; Hofstetter W; Klenke FM
    Bone; 2014 Dec; 69():80-8. PubMed ID: 25245204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alendronate on bone formation and osteoclastic resorption after implantation of beta-tricalcium phosphate.
    Tanaka T; Saito M; Chazono M; Kumagae Y; Kikuchi T; Kitasato S; Marumo K
    J Biomed Mater Res A; 2010 May; 93(2):469-74. PubMed ID: 19582838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mouse osteoclast K-Cl Co-transporter-1 and its role during bone resorption.
    Kajiya H; Okamoto F; Li JP; Nakao A; Okabe K
    J Bone Miner Res; 2006 Jul; 21(7):984-92. PubMed ID: 16813519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: a pilot study.
    Taylor JC; Cuff SE; Leger JP; Morra A; Anderson GI
    Int J Oral Maxillofac Implants; 2002; 17(3):321-30. PubMed ID: 12074446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive and active in vitro resorption of calcium and magnesium phosphate cements by osteoclastic cells.
    Grossardt C; Ewald A; Grover LM; Barralet JE; Gbureck U
    Tissue Eng Part A; 2010 Dec; 16(12):3687-95. PubMed ID: 20673025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resorbability of bone substitute biomaterials by human osteoclasts.
    Schilling AF; Linhart W; Filke S; Gebauer M; Schinke T; Rueger JM; Amling M
    Biomaterials; 2004 Aug; 25(18):3963-72. PubMed ID: 15046886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage colony stimulating factor increases bone resorption in dispersed osteoclast cultures by increasing osteoclast size.
    Lees RL; Heersche JN
    J Bone Miner Res; 1999 Jun; 14(6):937-45. PubMed ID: 10352102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review paper: behavior of ceramic biomaterials derived from tricalcium phosphate in physiological condition.
    Kamitakahara M; Ohtsuki C; Miyazaki T
    J Biomater Appl; 2008 Nov; 23(3):197-212. PubMed ID: 18996965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclastic resorption of apatite formed on apatite- and wollastonite-containing glass-ceramic by a simulated body fluid.
    Yamada S; Nakamura T; Kokubo T; Oka M; Yamamuro T
    J Biomed Mater Res; 1994 Nov; 28(11):1357-63. PubMed ID: 7829566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.